Sorry, no content matched your criteria.
Featured Story
Two of the Best Biotech Stocks to Buy Now
Since April 11, Gilead Sciences (Nasdaq: GILD) has scored peak gains of a 74.2% - or more than 175% annualized gains.
Some investors don't want to risk it all during a sell-off - but they still want to take advantage of the growth biotech stocks offer.
Since April 11, Gilead Sciences (Nasdaq: GILD) has scored peak gains of a 74.2% - or more than 175% annualized gains.
Some investors don't want to risk it all during a sell-off - but they still want to take advantage of the growth biotech stocks offer.